688513 Share Price Performance
CN¥55.17
24.19 (78.08%)
Price CN¥55.17
Share Pricen/a
Chengdu Easton Biopharmaceuticals Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
688513 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Chengdu Easton Biopharmaceuticals Co., Ltd. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 22, 2026
- 1.62
- 100.00%
- 21.27%
- 4.6%
About 688513
- Founded
- 2009
- Employees
- 1522
- CEO
- WebsiteView website
Chengdu Easton Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms comprising capsules, tablets, and injections, as well as active pharmaceutical ingredients (API). It also offers API products, such as Apixaban for cardiovascular applications; Apualutamide, Bosutinib, Dacomitinib, Ibrutinib, Nilotinib HCL, Nintedanib, Relugolix, and Ruxolitinib Phosphate for oncological applications; Bricaracetam and Lacosamide for neurological and psychiatric applications; and Empagliflozin for anti-diabetic applications. The company was founded in 2009 and is based in Chengdu, China.
